a-drug-is-developed-to-specifically-inhibit-receptor-serinethreonine-kinases-wha

Question

A drug is developed to specifically inhibit receptor serine/threonine kinases. What would be the expected effect on the TGF-beta signaling pathway?

Accepted Answer

Inhibition of the pathway due to lack of receptor activation.

Answer

No effect on the pathway.

Answer

Increased activation of the pathway.

Answer

Complete degradation of the receptor.